Award
Delivery Order #SPE2DR26F75MZ
AmerisourceBergen Awarded Delivery Order for NovoLog FlexPen
Buyer
Defense Logistics Agency
Award Amount
$36,996.96
Ceiling
$36,996.96
Awarded
March 03, 2026
Period of Performance
Mar 03, 2026 – Mar 04, 2026
Identifier
SPE2DR26F75MZ
NAICS
424210
This award represents a delivery order contract under an existing indefinite delivery vehicle (IDV) held by AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The contract involves the procurement of NovoLog 100 Unit/ml FlexPen 3ml insulin units, essential for diabetes treatment. This delivery order supports the agency's ongoing pharmaceutical supply chain, ensuring timely access to critical medications that impact patient care. The scope encompasses the delivery of a specified quantity of NovoLog insulin, highlighting the agency's commitment to maintaining consistent healthcare supplies. The order was issued under the IDV contract SPE2DR25D1202 with a brief performance window of one day, indicating a timely and focused fulfillment. This contract was awarded competitively under the broader IDV framework, reflecting the structured procurement approach for pharmaceutical products. The award reinforces public health infrastructure by sustaining vital drug availability through established supply channels.
Description
4571020091!NOVOLOG 100 UNIT/ML FLEXPEN 3ML